Laplace Interventional, Inc
Clinical trials sponsored by Laplace Interventional, Inc, explained in plain language.
-
A new Catheter-Based valve could fix a leaky heart valve without surgery
Disease control Recruiting nowThis trial tests a new device, the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System, designed to replace the tricuspid valve in people with severe, symptomatic tricuspid regurgitation. The procedure is done through a catheter, avoiding open-heart surgery. The study…
Phase: NA • Sponsor: Laplace Interventional, Inc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New heart valve device tested in canada for severe leaky valve
Disease control Recruiting nowThis early study tests a new device called the Laplace TTVR System, which is designed to replace the tricuspid valve without open-heart surgery. It involves 15 people aged 60-90 with severe tricuspid regurgitation that continues despite medication. The main goal is to see if the …
Phase: NA • Sponsor: Laplace Interventional, Inc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC